The world's first endpoint thrombin generation test that measures the prothrombinase complex formed in dependence on FVIII.
We offer a high-sensitivity thrombin generation test tool, the 'SMAT(R)-FVIII/IX Kit', which measures the prothrombinase complex formed through the crosstalk reaction between the tissue factor coagulation pathway and the factor VIII and factor IX pathways. This tool can be applied in research investigating blood coagulation abnormalities and changes in patients with thrombosis or bleeding disorders. Please feel free to consult us if you have any requests. 【Features】 - Coagulation test targeting trace amounts of prothrombinase formed in the early stages of coagulation - Quantification of thrombin dependent on crosstalk reactions - Evaluation of the functional enhancement or reduction of the tissue factor coagulation pathway - Assessment of the reduced activity of factor VIII and factor IX, as seen in hemophilia - Evaluation of inhibitors against activated factor X and factor XI *For more details, please download the PDF or feel free to contact us.
Inquire About This Product
basic information
【Applicable Research】 ■ Research on blood coagulation abnormalities and changes in patients with thrombosis or bleeding ■ Development of therapeutic and preventive drugs for diseases involving bleeding ■ Research on the side effects of antithrombotic drugs *For more details, please download the PDF or feel free to contact us.
Price range
P2
Delivery Time
Applications/Examples of results
*For more details, please download the PDF and check it. If you have any technical questions, please feel free to contact us.*
catalog（1）
Download All Catalogs
Company information
Our company is engaged in the research and development of in vitro blood testing and diagnostic drugs, as well as testing equipment, based on cutting-edge research results in thrombosis and hemostasis, with the aim of applying these to the diagnosis of thrombotic and hemorrhagic diseases. We hope to assist patients suffering from diseases related to thrombosis in receiving safe and secure treatment, and we wish to contribute, even in a small way, to the advancement of the field of thrombosis and hemostasis. Please feel free to consult us if you have any requests.
